Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.
Jackson GH et al. Br J Haematol. 2014 Mar 27. doi: 10.1111/bjh.12861. [Epub ahead of print].

Carfilzomib-related acute kidney injury may be prevented by N-acetyl-L-cysteine.
Wanchoo R et al. J Oncol Pharm Pract. 2014 Apr 18. [Epub ahead of print].

Pancreatic plasmacytoma with biliary obstruction as a manifestation of multiple myeloma relapse.
Castellani L et al. Gastroenterol Hepatol. 2014 Apr 17. pii: S0210-5705(13)00258-6. doi: 10.1016/j.gastrohep.2013.10.004. [Epub ahead of print].

Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.
Undas A et al. Eur J Clin Invest. 2014 Apr 16. doi: 10.1111/eci.12269. [Epub ahead of print].

Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasone.
Sun HL et al. Leuk Lymphoma. 2014 Apr 17. [Epub ahead of print].

Montefusco V et al. Leuk Lymphoma. 2014 Apr 15. [Epub ahead of print].

Treatment of acute kidney injury with cast nephropathy.
Walther C et al. Clin Nephrol. 2014 Apr 14. [Epub ahead of print].

Positron emission tomography findings in a patient with multiple myeloma of polymyalgia rheumatica-like symptoms caused by paraneoplastic syndrome.
Suzuki S et al. BMJ Case Rep. 2014 Apr 9;2014. pii: bcr2013203326. doi: 10.1136/bcr-2013-203326.

Visceral leishmaniasis in a patient with relapsed multiple myeloma receiving high-dose melphalan and autologous stem cell transplantation.
Radujkovic A et al. Leuk Lymphoma. 2014 Apr 8. [Epub ahead of print].

Very Low Rate of Readmission after an Early Discharge Outpatient Model for Autografting in Multiple Myeloma Patients: An Italian Multicenter Retrospective Study.
Martino M et al. Biol Blood Marrow Transplant. 2014 Mar 31. pii: S1083-8791(14)00200-6. doi: 10.1016/j.bbmt.2014.03.027. [Epub ahead of print].